Sandoval, C <br/><br/>
Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jun 1993 
 - 1039-45 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1993.11.6.1039  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Alkylating Agents--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Child<br/>Combined Modality Therapy<br/>Dactinomycin--adverse effects<br/>Doxorubicin--adverse effects<br/>Female<br/>Humans<br/>Intercalating Agents--adverse effects<br/>Leukemia, Myeloid--etiology<br/>Male<br/>Neoplasms, Second Primary--etiology<br/>Podophyllotoxin--adverse effects<br/>Radiotherapy--adverse effects<br/>Topoisomerase II Inhibitors<br/>Translocation, Genetic